Inventor · disambiguated record
Seblewongel Asrat
Also filed as: ASRAT SEBLEWONGEL
1 granted patent·3 pending applications·1 citations·filing 2020–2024
17Inventor score
Files withREGENERON PHARMA4
Top patents by PatentIndex Score
4 records- 0179US11964016B2Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergyREGENERON PHARMA·Filed 2020·Granted Apr 23, 2024·1 cites·99 claims
- 0271US2024350625A1Combination of il-4/il-13 pathway inhibitors and plasma cell abalation for treating allergyREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0359US2024350626A1Methods for treating eosinophilic gastroenteritis by administering an il-4r antagonistREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0456US2023349919A1Methods Of Mapping Antigen Specificity To Antibody-Secreting CellsREGENERON PHARMA·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Seblewongel Asrat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →